Drug Delivery System of Hepatocyte Growth Factor for the Treatment of Vocal Fold Scarring in a Canine Model

Abstract

Objectives:

Vocal fold scarring remains a therapeutic challenge. Previous studies have indicated that hepatocyte growth factor (HGF), a strong antifibrotic element, has therapeutic potential for restoring scarred vocal folds. To enhance the effect of HGF in vivo, we developed a novel drug delivery system (DDS) in which HGF is embedded in gelatin hydrogel and continuously released over a period of 2 weeks. In the present study we investigated the therapeutic efficacy of the HGF DDS on vocal fold scarring by using a canine model.

Methods:

The vocal folds of 8 beagles were unilaterally scarred by stripping the entire layer of the lamina propria. The contralateral vocal folds were kept intact as normal controls. One month after the procedure, hydrogels (0.5 mL) containing 1 μg of HGF were injected into the scarred vocal folds of 4 dogs (HGF-treated group), whereas hydrogels containing saline solution were injected in the other 4 dogs (sham group). Histologic and vibratory examinations were completed for each group 6 months after the initial surgery.

Results:

The excised larynx experiments showed significantly better vibration in terms of mucosal wave amplitude and glottal closure in the HGF-treated group compared to the sham group. Histologic evaluation of the vocal folds indicated remarkable reduction in collagen deposition and tissue contraction, with favorable restoration of hyaluronic acid and elastin in the HGF-treated group.

Conclusions:

The present findings suggest that the novel HGF DDS may provide favorable effects in restoring the vibratory properties of scarred vocal folds.

Keywords

drug delivery system gelatin hydrogel hepatocyte growth factor vocal fold scarring

Get full access to this article

View all access options for this article.

References

Ford

Bless

. Collagen injection in the scarred vocal fold. J Voice 1987;1:116–8.

Staskowski

Ford

Inagi

. The histologic fate of autologous collagen injected into the canine vocal fold. Otolaryngol Head Neck Surg 1998;118:187–90.

Kriesel

Thibeault

Chan

. Treatment of vocal fold scarring: Rheological and histological measures of homologous collagen matrix. Ann Otol Rhinol Laryngol 2002;111:884–9.

Brandenburg

Kirkham

Koschkee

. Vocal cord augmentation with autogenous fat. Laryngoscope 1992;102:495–500.

Thibeault

Gray

Bless

Chan

Ford

. Histologic and rheologic characterization of vocal fold scarring. J Voice 2002;16:96–104.

Gray

Titze

Chan

Hammond

. Vocal fold proteoglycans and their influence on biomechanics. Laryngoscope 1999;109:845–54.

Savani

Bagli

Harrison

Turley

. The role of hyaluronan-receptor interactions in wound repair. In: Garg

Longaker

, eds. Scarless wound healing. New York, NY: Marcel Dekker, 2000:115–37.

Matsumoto

Nakamura

. Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. Biochem Biophys Res Commun 1997;239:639–44.

Hirano

Bless

Heisey

Ford

. Roles of hepatocyte growth factor and transforming growth factor betal in production of extracellular matrix by canine vocal fold fibroblasts. Laryngoscope 2003;113:144–8.

10.

Hirano

Bless

Rousseau

. Prevention of vocal fold scarring by topical injection of hepatocyte growth factor in a rabbit model. Laryngoscope 2004;114:548–56.

11.

Hirano

Bless

Nagai

. Growth factor therapy for vocal fold scarring in a canine model. Ann Otol Rhinol Laryngol 2004;113:777–85.

12.

Ozeki

Ishii

Hirano

Tabata

. Controlled release of hepatocyte growth factor from gelatin hydrogels based on hydrogel degradation. J Drug Target 2001;9:461–71.

13.

Ikada

Tabata

. Protein release from gelatin matrices. Adv Drug Deliv Rev 1998;31:287–301.

14.

Sakaguchi

Tambara

Sakakibara

. Control-released hepatocyte growth factor prevents the progression of heart failure in stroke-prone spontaneously hypertensive rats. Ann Thorac Surg 2005;79:1627–34.

15.

Haraguchi

Okada

Tabata

Maniwa

Hayashi

Okita

. Controlled release of basic fibroblast growth factor from gelatin hydrogel sheet improves structural and physiological properties of vein graft in rat. Arterioscler Thromb Vasc Biol 2007;27:548–55.

16.

Nakae

Kamiya

Naruse

. Effects of basic fibroblast growth factor on experimental diabetic neuropathy in rats. Diabetes 2006;55:1470–7.

17.

Hokugo

Sawada

Hokugo

. Controlled release of platelet growth factors enhances bone regeneration at rabbit calvaria. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;104:44–8.

18.

Hori

Sotozono

Hamuro

. Controlled-release of epidermal growth factor from cationized gelatin hydrogel enhances corneal epithelial wound healing. J Control Release 2007;118:169–76.

19.

Hirano

. Phonosurgery: Past, present, and future. Trans Am Broncho-Esophagol Assoc 1995:25–30.

20.

Rousseau

Hirano

Chan

. Characterization of chronic vocal fold scarring in a rabbit model. J Voice 2004;18:116–24.

21.

Rousseau

Hirano

Scheidt

. Characterization of vocal fold scarring in a canine model. Laryngoscope 2003;113:620–7.

22.

Hirano

Bless

Rousseau

Welham

Scheidt

Ford

. Fibronectin and adhesion molecules on canine scarred vocal folds. Laryngoscope 2003;113:966–72.

23.

Kanemaru

Nakamura

Omori

. Regeneration of the vocal fold using autologous mesenchymal stem cells. Ann Otol Rhinol Laryngol 2003;112:915–20.

24.

Kanemaru

Nakamura

Yamashita

. Destiny of autologous bone marrow-derived stromal cells implanted in the vocal fold. Ann Otol Rhinol Laryngol 2005;114:907–12.